One of Biovalence Technologies' business strategies is to license-out either its library of molecules or its intellectual property to research institutes, companies in the healthcare space to develop and commercialize their own novel drugs. In this way, we are assured to save as many lives as possible.

For more information on licensing-in collaboration, please email to admin@biovalence.com